| Literature DB >> 28211972 |
Laura S Farach1, William T Gibson2, Steven P Sparagana3, Mark Nellist4, Connie T R M Stumpel5, Marja Hietala6, Elliott Friedman7, Deborah A Pearson8, Susan P Creighton9, Annemiek Wagemans5,10, Reveel Segel11, Efrat Ben-Shalom12, Kit Sing Au1, Hope Northrup1.
Abstract
Tuberous sclerosis complex (TSC) is an autosomal dominantly inherited disorder with variable expressivity associated with hamartomatous tumors, abnormalities of the skin, and neurologic problems including seizures, intellectual disability, and autism. TSC is caused by pathogenic variants in either TSC1 or TSC2. In general, TSC2 pathogenic variants are associated with a more severe phenotype than TSC1 pathogenic variants. Here, we report a pathogenic TSC2 variant, c.1864C>T, p.(Arg622Trp), associated with a mild phenotype, with most carriers meeting fewer than two major clinical diagnostic criteria for TSC. This finding has significant implications for counseling patients regarding prognosis. More patient data are required before changing the surveillance recommendations for patients with the reported variant. However, consideration should be given to tailoring surveillance recommendations for all pathogenic TSC1 and TSC2 variants with documented milder clinical sequelae.Entities:
Keywords: TSC2; genetic counseling; genotype-phenotype association; rhabdomyoma; tuberous sclerosis complex
Mesh:
Substances:
Year: 2017 PMID: 28211972 DOI: 10.1002/ajmg.a.38083
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802